Amaia Rodríguez Selected Research

Glycerol (Glycerine)

1/2020	Aquaporin-11 Contributes to TGF-β1-Induced Endoplasmic Reticulum Stress in Human Visceral Adipocytes: Role in Obesity-Associated Inflammation.
1/2018	Pancreatic Aquaporin-7: A Novel Target for Anti-diabetic Drugs?
1/2017	Physical exercise remodels visceral adipose tissue and mitochondrial lipid metabolism in rats fed a high-fat diet.
1/2017	Gastric Plication Improves Glycemia Partly by Restoring the Altered Expression of Aquaglyceroporins in Adipose Tissue and the Liver in Obese Rats.
9/2015	Sleeve Gastrectomy Reduces Hepatic Steatosis by Improving the Coordinated Regulation of Aquaglyceroporins in Adipose Tissue and Liver in Obese Rats.
7/2015	Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice.
1/2015	Sexual Dimorphism of Adipose and Hepatic Aquaglyceroporins in Health and Metabolic Disorders.
11/2014	Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis.
1/2013	Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of Non-Alcoholic Fatty Liver Disease.
5/2011	Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amaia Rodríguez Research Topics

Disease

72	Obesity 01/2022 - 03/2006
41	Inflammation (Inflammations) 01/2022 - 03/2006
27	Weight Loss (Weight Reduction) 01/2022 - 03/2006
26	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2007
26	Insulin Resistance 01/2021 - 09/2006
13	Non-alcoholic Fatty Liver Disease 11/2021 - 07/2012
12	Morbid Obesity 01/2022 - 03/2006
10	Body Weight (Weight, Body) 09/2019 - 09/2002
7	Fibrosis (Cirrhosis) 01/2022 - 01/2014
6	Fatty Liver 01/2022 - 01/2013
6	Hypoxia (Hypoxemia) 08/2021 - 07/2011
5	Metabolic Diseases (Metabolic Disease) 01/2022 - 03/2013
5	Glucose Intolerance 01/2022 - 10/2014
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2007
4	Dyslipidemias (Dyslipidemia) 11/2021 - 11/2014
4	Colonic Neoplasms (Colon Cancer) 08/2021 - 07/2011
4	Hyperglycemia 01/2021 - 04/2011
4	Neoplasms (Cancer) 01/2017 - 10/2013
3	Weight Gain 01/2022 - 01/2017
3	Anorexia Nervosa 11/2019 - 03/2016
3	Hyperplasia 01/2019 - 10/2015
3	Hypertrophy 01/2019 - 10/2015
3	Hypertension (High Blood Pressure) 03/2010 - 08/2006
2	Hyperinsulinism (Hyperinsulinemia) 06/2021 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 09/2017
2	Necrosis 10/2018 - 07/2011
2	Heart Failure 09/2017 - 03/2010
1	Carcinogenesis 08/2021
1	Starvation 01/2021

Drug/Important Bio-Agent (IBA)

21	LeptinIBA 04/2021 - 09/2002
18	Messenger RNA (mRNA)IBA 01/2022 - 03/2006
16	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2009
15	AdipokinesIBA 04/2020 - 01/2007
13	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 09/2006
13	Glycerol (Glycerine)FDA LinkGeneric 01/2020 - 07/2006
12	LipidsIBA 01/2022 - 10/2008
9	AdiponectinIBA 09/2019 - 11/2004
8	GhrelinIBA 11/2019 - 03/2010
8	OsteopontinIBA 01/2017 - 09/2007
7	CytokinesIBA 01/2022 - 11/2007
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2014
6	Protein Isoforms (Isoforms)IBA 01/2022 - 03/2010
6	Triglycerides (Triacylglycerol)IBA 01/2018 - 07/2006
5	LipopolysaccharidesIBA 08/2021 - 11/2004
5	Insulin (Novolin)FDA Link 01/2021 - 10/2008
5	Interleukin-8 (Interleukin 8)IBA 01/2021 - 01/2017
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2011
5	AquaglyceroporinsIBA 09/2015 - 04/2011
4	Angiopoietin-Like Protein 8IBA 11/2021 - 10/2014
4	Hormones (Hormone)IBA 06/2021 - 09/2002
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 06/2009
3	Chemotactic FactorsIBA 01/2022 - 01/2011
3	Conditioned Culture MediaIBA 01/2022 - 01/2021
3	salicylhydroxamic acid (SHAM)IBA 11/2021 - 02/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 11/2007
3	OrexinsIBA 01/2019 - 03/2016
3	des-n-octanoyl ghrelinIBA 01/2019 - 03/2010
3	Heme (Haem)IBA 01/2018 - 01/2017
3	HDL CholesterolIBA 01/2018 - 10/2014
3	IronIBA 01/2018 - 09/2013
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2017 - 03/2006
3	Lipocalin-2IBA 05/2015 - 07/2011
2	Biological ProductsIBA 01/2022 - 06/2021
2	Dietary Fats (Dietary Fat)IBA 01/2022 - 06/2021
2	InterleukinsIBA 08/2021 - 12/2016
2	InflammasomesIBA 01/2021 - 01/2021
2	Interleukin-18 (Interleukin 18)IBA 01/2021 - 01/2021
2	fibroblast growth factor 21IBA 01/2021 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2020 - 09/2012
2	Peptides (Polypeptides)IBA 01/2019 - 03/2016
2	C-Reactive ProteinIBA 01/2017 - 01/2017
2	Nonesterified Fatty Acids (NEFA)IBA 01/2017 - 01/2007
2	TenascinIBA 01/2016 - 10/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011 - 08/2010
1	Cathepsin GIBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	prouroguanylinIBA 01/2022
1	preproguanylinIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	guanylinIBA 01/2022
1	microfibrillar proteinIBA 08/2021
1	NeuropeptidesIBA 06/2021
1	Interleukin-33IBA 01/2021
1	Muramidase (Lysozyme)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2020
1	AcidsIBA 01/2020
1	EnzymesIBA 01/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2020
1	Succinic Acid (Succinate)IBA 10/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2019
1	Exenatide (Byetta)FDA Link 04/2019
1	Indicators and Reagents (Reagents)IBA 02/2019
1	AlarminsIBA 01/2019

Therapy/Procedure

16	Bariatric Surgery 01/2022 - 08/2014
14	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 03/2006
11	Gastrectomy 01/2022 - 09/2011
5	Caloric Restriction 01/2022 - 09/2012
3	Therapeutics 06/2021 - 01/2016
3	Operative Surgical Procedures 01/2018 - 02/2012